The Serum Tissue Factor Level in Lung Cancer Patients as a Prognostic Factor
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00257179|
Recruitment Status : Unknown
Verified June 2005 by National Taiwan University Hospital.
Recruitment status was: Recruiting
First Posted : November 22, 2005
Last Update Posted : March 14, 2006
|Condition or disease|
The staging of lung cancer was according to tumor size, involvement of lymph node and metastatic status. But there is a different prognosis in cancer patients of the same stage. The coagulation status of cancer patients was considered as an important possible prognostic factor. So in this study, we want to evaluate patients' coagulation status and find the relation of coagulation status and cancer status.
We thus propose a prospective study using coagulation factors in order to search for the relationship between cancer stage and pre-coagulation status in Taiwanese lung cancer patients. We will also evaluate the potential use of tissue factor as a prognosis predictor in lung cancer patients.
|Study Type :||Observational|
|Enrollment :||200 participants|
|Observational Model:||Natural History|
|Study Start Date :||June 2005|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00257179
|Contact: Chong-Jen Yu, M.D., Ph.D.||firstname.lastname@example.org|
|National Taiwan University Hospital||Recruiting|
|Contact: Chong-Jen Yu, M.D., Ph.D. 886-2-2356-2905|
|Principal Investigator:||Chong-Jen Yu, M.D., Ph.D.||National Taiwan University Hospital|